AC
ESPR

Aisling Capital’s Esperion Therapeutics ESPR Stock Holding History

Aisling Capital’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-837,125
Closed -$42M – 13
2017
Q3 		$42M Hold
837,125
– – 6.89% 4
2017
Q2 		$38.7M Hold
837,125
– – 6.64% 4
2017
Q1 		$29.6M Sell
837,125
-800,000
-49% -$18.3M 5.38% 6
2016
Q4 		$20.5M Hold
1,637,125
– – 4.77% 6
2016
Q3 		$22.7M Hold
1,637,125
– – 4.67% 9
2016
Q2 		$16.2M Hold
1,637,125
– – 3.82% 12
2016
Q1 		$27.7M Hold
1,637,125
– – 5.54% 8
2015
Q4 		$36.4M Hold
1,637,125
– – 6.28% 5
2015
Q3 		$38.6M Hold
1,637,125
– – 6.79% 5
2015
Q2 		$134M Sell
1,637,125
-417,469
-20% -$40.9M 19.93% 1
2015
Q1 		$190M Hold
2,054,594
– – 24.9% 1
2014
Q4 		$83.1M Hold
2,054,594
– – 12.6% 1
2014
Q3 		$50.3M Hold
2,054,594
– – 9.75% 2
2014
Q2 		$32.5M Buy
+2,054,594
New +$29.7M 9.41% 7

Other funds holding ESPR

BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return